SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-21-014100
Filing Date
2021-11-02
Accepted
2021-11-02 16:11:13
Documents
15
Period of Report
2021-11-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K agrx-20211102x8k.htm   iXBRL 8-K 36281
2 EX-99.1 agrx-20211102xex99d1.htm EX-99.1 221209
3 GRAPHIC agrx-20211102xex99d1002.jpg GRAPHIC 20625
4 GRAPHIC agrx-20211102xex99d1001.jpg GRAPHIC 23924
  Complete submission text file 0001558370-21-014100.txt   451396

Data Files

Seq Description Document Type Size
5 EX-101.SCH agrx-20211102.xsd EX-101.SCH 3181
6 EX-101.LAB agrx-20211102_lab.xml EX-101.LAB 15271
7 EX-101.PRE agrx-20211102_pre.xml EX-101.PRE 9738
8 EXTRACTED XBRL INSTANCE DOCUMENT agrx-20211102x8k_htm.xml XML 4711
Mailing Address 101 POOR FARM ROAD PRINCETON NJ 08540-1715
Business Address 101 POOR FARM ROAD PRINCETON NJ 08540-1715 609-683-1880
AGILE THERAPEUTICS INC (Filer) CIK: 0001261249 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36464 | Film No.: 211371428
SIC: 2834 Pharmaceutical Preparations